Some progress has been made in understanding human PBC, including identifying the target mitochondrial autoantigens which induce the characteristic anti-pyruvate dehydrogenase complex (anti-PDC-E2) autoantibodies, mapping the T and B cell autoantigenic epitopes, and defining mechanisms of tissue destruction (Lleo et al. 2020). Here, DLAT is linked to primary biliary cholangitis.